AZIN2_RAT
ID AZIN2_RAT Reviewed; 457 AA.
AC D4A693;
DT 01-OCT-2014, integrated into UniProtKB/Swiss-Prot.
DT 03-APR-2013, sequence version 2.
DT 03-AUG-2022, entry version 77.
DE RecName: Full=Antizyme inhibitor 2;
DE Short=AzI2;
DE AltName: Full=Ornithine decarboxylase-like protein;
DE Short=ODC-like protein;
DE AltName: Full=ornithine decarboxylase paralog;
DE Short=ODC-p;
GN Name=Azin2; Synonyms=Adc, Odcp;
OS Rattus norvegicus (Rat).
OC Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC Murinae; Rattus.
OX NCBI_TaxID=10116;
RN [1]
RP NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC STRAIN=Brown Norway;
RX PubMed=15057822; DOI=10.1038/nature02426;
RA Gibbs R.A., Weinstock G.M., Metzker M.L., Muzny D.M., Sodergren E.J.,
RA Scherer S., Scott G., Steffen D., Worley K.C., Burch P.E., Okwuonu G.,
RA Hines S., Lewis L., Deramo C., Delgado O., Dugan-Rocha S., Miner G.,
RA Morgan M., Hawes A., Gill R., Holt R.A., Adams M.D., Amanatides P.G.,
RA Baden-Tillson H., Barnstead M., Chin S., Evans C.A., Ferriera S.,
RA Fosler C., Glodek A., Gu Z., Jennings D., Kraft C.L., Nguyen T.,
RA Pfannkoch C.M., Sitter C., Sutton G.G., Venter J.C., Woodage T., Smith D.,
RA Lee H.-M., Gustafson E., Cahill P., Kana A., Doucette-Stamm L.,
RA Weinstock K., Fechtel K., Weiss R.B., Dunn D.M., Green E.D.,
RA Blakesley R.W., Bouffard G.G., De Jong P.J., Osoegawa K., Zhu B., Marra M.,
RA Schein J., Bosdet I., Fjell C., Jones S., Krzywinski M., Mathewson C.,
RA Siddiqui A., Wye N., McPherson J., Zhao S., Fraser C.M., Shetty J.,
RA Shatsman S., Geer K., Chen Y., Abramzon S., Nierman W.C., Havlak P.H.,
RA Chen R., Durbin K.J., Egan A., Ren Y., Song X.-Z., Li B., Liu Y., Qin X.,
RA Cawley S., Cooney A.J., D'Souza L.M., Martin K., Wu J.Q.,
RA Gonzalez-Garay M.L., Jackson A.R., Kalafus K.J., McLeod M.P.,
RA Milosavljevic A., Virk D., Volkov A., Wheeler D.A., Zhang Z., Bailey J.A.,
RA Eichler E.E., Tuzun E., Birney E., Mongin E., Ureta-Vidal A., Woodwark C.,
RA Zdobnov E., Bork P., Suyama M., Torrents D., Alexandersson M., Trask B.J.,
RA Young J.M., Huang H., Wang H., Xing H., Daniels S., Gietzen D., Schmidt J.,
RA Stevens K., Vitt U., Wingrove J., Camara F., Mar Alba M., Abril J.F.,
RA Guigo R., Smit A., Dubchak I., Rubin E.M., Couronne O., Poliakov A.,
RA Huebner N., Ganten D., Goesele C., Hummel O., Kreitler T., Lee Y.-A.,
RA Monti J., Schulz H., Zimdahl H., Himmelbauer H., Lehrach H., Jacob H.J.,
RA Bromberg S., Gullings-Handley J., Jensen-Seaman M.I., Kwitek A.E.,
RA Lazar J., Pasko D., Tonellato P.J., Twigger S., Ponting C.P., Duarte J.M.,
RA Rice S., Goodstadt L., Beatson S.A., Emes R.D., Winter E.E., Webber C.,
RA Brandt P., Nyakatura G., Adetobi M., Chiaromonte F., Elnitski L.,
RA Eswara P., Hardison R.C., Hou M., Kolbe D., Makova K., Miller W.,
RA Nekrutenko A., Riemer C., Schwartz S., Taylor J., Yang S., Zhang Y.,
RA Lindpaintner K., Andrews T.D., Caccamo M., Clamp M., Clarke L., Curwen V.,
RA Durbin R.M., Eyras E., Searle S.M., Cooper G.M., Batzoglou S., Brudno M.,
RA Sidow A., Stone E.A., Payseur B.A., Bourque G., Lopez-Otin C., Puente X.S.,
RA Chakrabarti K., Chatterji S., Dewey C., Pachter L., Bray N., Yap V.B.,
RA Caspi A., Tesler G., Pevzner P.A., Haussler D., Roskin K.M., Baertsch R.,
RA Clawson H., Furey T.S., Hinrichs A.S., Karolchik D., Kent W.J.,
RA Rosenbloom K.R., Trumbower H., Weirauch M., Cooper D.N., Stenson P.D.,
RA Ma B., Brent M., Arumugam M., Shteynberg D., Copley R.R., Taylor M.S.,
RA Riethman H., Mudunuri U., Peterson J., Guyer M., Felsenfeld A., Old S.,
RA Mockrin S., Collins F.S.;
RT "Genome sequence of the Brown Norway rat yields insights into mammalian
RT evolution.";
RL Nature 428:493-521(2004).
RN [2]
RP SUBCELLULAR LOCATION, AND INDUCTION.
RX PubMed=19718454; DOI=10.1371/journal.pone.0006858;
RA Kanerva K., Lappalainen J., Makitie L.T., Virolainen S., Kovanen P.T.,
RA Andersson L.C.;
RT "Expression of antizyme inhibitor 2 in mast cells and role of polyamines as
RT selective regulators of serotonin secretion.";
RL PLoS ONE 4:E6858-E6858(2009).
CC -!- FUNCTION: Antizyme inhibitor (AZI) protein that positively regulates
CC ornithine decarboxylase (ODC) activity and polyamine uptake. AZI is an
CC enzymatically inactive ODC homolog that counteracts the negative effect
CC of ODC antizymes (AZs) OAZ1, OAZ2 and OAZ3 on ODC activity by competing
CC with ODC for antizyme-binding. Inhibits antizyme-dependent ODC
CC degradation and releases ODC monomers from their inactive complex with
CC antizymes, leading to formation of the catalytically active ODC
CC homodimer and restoring polyamine production. Participates in the
CC morphological integrity of the trans-Golgi network (TGN) and functions
CC as a regulator of intracellular secretory vesicle trafficking.
CC {ECO:0000250|UniProtKB:Q8BVM4, ECO:0000250|UniProtKB:Q96A70}.
CC -!- SUBUNIT: Monomer. Interacts with OAZ1, OAZ2 and OAZ3; this interaction
CC disrupts the interaction between the antizyme and ODC1. Does not form a
CC heterodimer with ODC1. {ECO:0000250|UniProtKB:Q8BVM4,
CC ECO:0000250|UniProtKB:Q96A70}.
CC -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:19718454}. Cytoplasm
CC {ECO:0000250}. Cytoplasm, perinuclear region {ECO:0000250}. Membrane
CC {ECO:0000250}. Cytoplasmic vesicle {ECO:0000250}. Endoplasmic
CC reticulum-Golgi intermediate compartment {ECO:0000250}. Golgi
CC apparatus, cis-Golgi network {ECO:0000250}. Golgi apparatus, trans-
CC Golgi network {ECO:0000250}. Cytoplasmic granule
CC {ECO:0000269|PubMed:19718454}. Cell projection, axon {ECO:0000250}.
CC Cell projection, dendrite {ECO:0000250}. Perikaryon {ECO:0000250}.
CC Note=Colocalizes with KDEL receptors in ER-Golgi intermediate
CC compartment (ERGIC). Translocates from the ERGIC structure to the
CC cytoplasm in a antizyme-dependent manner. Localizes with vesicle-
CC associated membrane protein VAMP8 in the vicinity of the plasma
CC membrane within serotonin-containing secretory granules. Detected as
CC vesicle-like pattern in neurite outgrowths. Localizes to the vesicular
CC compartments of the secretory pathway, predominantly in the trans-Golgi
CC network (TGN) (By similarity). Localizes with vesicle-associated
CC membrane protein VAMP8 in the vicinity of the plasma membrane within
CC serotonin-containing secretory granules. {ECO:0000250}.
CC -!- INDUCTION: Up-regulated in activated mast cells (MC) (at protein
CC level). {ECO:0000269|PubMed:19718454}.
CC -!- DOMAIN: The N-terminus domain is necessary for its localization to the
CC ER-Golgi intermediate compartment (ERGIC). {ECO:0000250}.
CC -!- PTM: Ubiquitinated, leading to its proteasomal degradation; a process
CC that is reduced in presence of antizymes. May also be degraded through
CC the lysosomal degradative pathway in a proteasomal-independent manner
CC (By similarity). {ECO:0000250}.
CC -!- MISCELLANEOUS: Arg-68 is present instead of the conserved Lys which
CC would otherwise be the covalent pyridoxal phosphate binding site.
CC {ECO:0000305}.
CC -!- SIMILARITY: Belongs to the Orn/Lys/Arg decarboxylase class-II family.
CC ODC antizyme inhibitor subfamily. {ECO:0000305}.
CC -!- CAUTION: Human ortholog was initially reported to have ornithine
CC decarboxylase or arginine decarboxylase activities, but it was later
CC found that the mouse ortholog does not possess neither of them.
CC {ECO:0000305}.
CC ---------------------------------------------------------------------------
CC Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC ---------------------------------------------------------------------------
DR EMBL; AABR06040008; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR EMBL; AABR06040009; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR EMBL; AABR06040010; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR EMBL; AABR06040011; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR AlphaFoldDB; D4A693; -.
DR SMR; D4A693; -.
DR STRING; 10116.ENSRNOP00000059346; -.
DR PaxDb; D4A693; -.
DR PRIDE; D4A693; -.
DR RGD; 1564776; Azin2.
DR eggNOG; KOG0622; Eukaryota.
DR InParanoid; D4A693; -.
DR Reactome; R-RNO-351143; Agmatine biosynthesis.
DR PRO; PR:D4A693; -.
DR Proteomes; UP000002494; Unplaced.
DR GO; GO:0030424; C:axon; ISS:UniProtKB.
DR GO; GO:0005801; C:cis-Golgi network; ISS:UniProtKB.
DR GO; GO:0005737; C:cytoplasm; IBA:GO_Central.
DR GO; GO:0031410; C:cytoplasmic vesicle; ISS:UniProtKB.
DR GO; GO:0030425; C:dendrite; ISS:UniProtKB.
DR GO; GO:0033116; C:endoplasmic reticulum-Golgi intermediate compartment membrane; ISS:UniProtKB.
DR GO; GO:1990005; C:granular vesicle; IDA:UniProtKB.
DR GO; GO:0005739; C:mitochondrion; ISO:RGD.
DR GO; GO:0005634; C:nucleus; IDA:UniProtKB.
DR GO; GO:0043204; C:perikaryon; ISS:UniProtKB.
DR GO; GO:0048471; C:perinuclear region of cytoplasm; ISS:UniProtKB.
DR GO; GO:0005802; C:trans-Golgi network; ISS:UniProtKB.
DR GO; GO:0030133; C:transport vesicle; ISS:UniProtKB.
DR GO; GO:0003824; F:catalytic activity; IEA:InterPro.
DR GO; GO:0042978; F:ornithine decarboxylase activator activity; ISS:UniProtKB.
DR GO; GO:0042177; P:negative regulation of protein catabolic process; ISS:UniProtKB.
DR GO; GO:0006591; P:ornithine metabolic process; ISO:RGD.
DR GO; GO:0043085; P:positive regulation of catalytic activity; ISS:UniProtKB.
DR GO; GO:1902269; P:positive regulation of polyamine transmembrane transport; ISS:UniProtKB.
DR GO; GO:0033387; P:putrescine biosynthetic process from ornithine; IBA:GO_Central.
DR GO; GO:0098629; P:trans-Golgi network membrane organization; ISS:UniProtKB.
DR Gene3D; 2.40.37.10; -; 1.
DR Gene3D; 3.20.20.10; -; 1.
DR InterPro; IPR009006; Ala_racemase/Decarboxylase_C.
DR InterPro; IPR031173; Azin2.
DR InterPro; IPR022643; De-COase2_C.
DR InterPro; IPR022657; De-COase2_CS.
DR InterPro; IPR022644; De-COase2_N.
DR InterPro; IPR000183; Orn/DAP/Arg_de-COase.
DR InterPro; IPR002433; Orn_de-COase.
DR InterPro; IPR029066; PLP-binding_barrel.
DR PANTHER; PTHR11482; PTHR11482; 1.
DR PANTHER; PTHR11482:SF4; PTHR11482:SF4; 1.
DR Pfam; PF02784; Orn_Arg_deC_N; 1.
DR Pfam; PF00278; Orn_DAP_Arg_deC; 1.
DR PRINTS; PR01179; ODADCRBXLASE.
DR PRINTS; PR01182; ORNDCRBXLASE.
DR SUPFAM; SSF50621; SSF50621; 1.
DR SUPFAM; SSF51419; SSF51419; 1.
DR PROSITE; PS00879; ODR_DC_2_2; 1.
PE 1: Evidence at protein level;
KW Cell projection; Cytoplasm; Cytoplasmic vesicle; Golgi apparatus; Membrane;
KW Nucleus; Reference proteome; Transport; Ubl conjugation.
FT CHAIN 1..457
FT /note="Antizyme inhibitor 2"
FT /id="PRO_0000430358"
FT REGION 115..138
FT /note="Necessary for polyamine uptake stimulation"
FT /evidence="ECO:0000250"
SQ SEQUENCE 457 AA; 49420 MW; B39AEF9E437F7830 CRC64;
MAGYLSESDF VMVEEGFSTR DLLEELTLGA SQATTGKVAA FFVADAVVRK HFCFLKYLPR
VRPFYAVRCN SSLGVLKVLA ELGLGFSCAS KAEMELVQHI GVPASKIICA NPCKQVAQIK
YAAKHGVRLL SFDNEVELAK VVKSHPSAKS WGEVLTLDAL GLHHTHRRVG CSLMFQASVI
ASVAQGYLEL VCQPFHIGSG CPDPQAYAQS IADARLVFQM GAELGHTMNI LDLGGGFPGL
EGAKVRFEEV TSVIGKNIPF YTPPPCHVPL RTHATKKMTS SDFCCRVHVT AKEKPLFSPF
LTEQTGAAPK SIVYHLDEGV YGVFNSVLFD NTCPTPALQK KPSADQPLYS SSLWGPAVDG
CDCVAEGLWL PQLQVGDWLV FDNMGAYTVD TKSLLGGTQA CRVTYAMSRL AWEALQGQLL
PAEEDQDAEG VCKPLSCGWE ITDSLCVGPV FTPASIM